You risk not just ineffective treatment, but harm from untested substances
In addition, healthcare systems may also see broader changes to their service requirements, driven by a downstream reduction in chronic diseases such as cardiovascular and diabetes (covered in further detail later in this section)
This dual crisis has catalyzed a pharmaceutical revolution, most notably in the development of highly effective GLP-1 receptor agonists
Severe, persistent, or worsening headaches, and especially any headache accompanied by vision changes, confusion, or neck stiffness, which the post says warrant immediate clinical evaluation to rule out serious causes
Hydroxypropyl-beta-cyclodextrin is being studied in a Phase 2 clinical trial of 90 patients with clinically diagnosed MCI, supported by a Precivity AD plasma biomarker showing high likelihood of a positive amyloid scan (NCT05607615)